Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Milvella is an Australian medical device company that specializes in the development of innovative surgical tools for the field of ophthalmology. The company's primary focus is on improving the outcomes of cataract surgery through its proprietary Sealed Capsule Irrigation (SCI) technology. Its flagship product, the Perfect Capsule, is a single-use device designed to create a fluid-tight seal within the lens capsule during surgery. This allows for the safe and effective removal of lens epithelial cells, which are the primary cause of Posterior Capsule Opacification (PCO). By preventing PCO, Milvella's technology reduces the need for secondary YAG laser procedures and improves long-term visual clarity for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Milvella.